1. ShepardCW, FinelliL, AlterMJ (2005) Global epidemiology of hepatitis C virus infection. The Lancet infectious diseases 5: 558–567.
2. NegroF, AlbertiA (2011) The global health burden of hepatitis C virus infection. Liver international : official journal of the International Association for the Study of the Liver 31 Suppl 2: 1–3.
3. ScheelTK, RiceCM (2013) Understanding the hepatitis C virus life cycle paves the way for highly effective therapies. Nature medicine 19: 837–849.
4. RubinA, AguileraV, BerenguerM (2011) Liver transplantation and hepatitis C. Clinics and research in hepatology and gastroenterology 35: 805–812.
5. FormanLM (2003) To transplant or not to transplant recurrent hepatitis C and liver failure. Clinics in liver disease 7: 615–629.
6. TimpeJM, StamatakiZ, JenningsA, HuK, FarquharMJ, et al. (2008) Hepatitis C virus cell-cell transmission in hepatoma cells in the presence of neutralizing antibodies. Hepatology 47: 17–24.
7. MorinTJ, BroeringTJ, LeavBA, BlairBM, RowleyKJ, et al. (2012) Human monoclonal antibody HCV1 effectively prevents and treats HCV infection in chimpanzees. PLoS pathogens 8: e1002895.
8. GottweinJM, BukhJ (2008) Cutting the gordian knot-development and biological relevance of hepatitis C virus cell culture systems. Advances in virus research 71: 51–133.
9. ZeiselMB, FofanaI, Fafi-KremerS, BaumertTF (2011) Hepatitis C virus entry into hepatocytes: molecular mechanisms and targets for antiviral therapies. Journal of hepatology 54: 566–576.
10. ScarselliE, AnsuiniH, CerinoR, RoccaseccaRM, AcaliS, et al. (2002) The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus. The EMBO journal 21: 5017–5025.
11. PileriP, UematsuY, CampagnoliS, GalliG, FalugiF, et al. (1998) Binding of hepatitis C virus to CD81. Science 282: 938–941.
12. MeulemanP, HesselgesserJ, PaulsonM, VanwolleghemT, DesombereI, et al. (2008) Anti-CD81 antibodies can prevent a hepatitis C virus infection in vivo. Hepatology 48: 1761–1768.
13. DavisGL (2006) Hepatitis C immune globulin to prevent HCV recurrence after liver transplantation: chasing windmills? Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 12: 1317–1319.
14. ManciniN, DiottiRA, PerottiM, SauttoG, ClementiN, et al. (2009) Hepatitis C virus (HCV) infection may elicit neutralizing antibodies targeting epitopes conserved in all viral genotypes. PloS one 4: e8254.
15. SchianoTD, CharltonM, YounossiZ, GalunE, PruettT, et al. (2006) Monoclonal antibody HCV-AbXTL68 in patients undergoing liver transplantation for HCV: results of a phase 2 randomized study. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 12: 1381–1389.
16. WitteveldtJ, EvansMJ, BitzegeioJ, KoutsoudakisG, OwsiankaAM, et al. (2009) CD81 is dispensable for hepatitis C virus cell-to-cell transmission in hepatoma cells. The Journal of general virology 90: 48–58.
17. LeeY, El AndaloussiS, WoodMJ (2012) Exosomes and microvesicles: extracellular vesicles for genetic information transfer and gene therapy. Human molecular genetics 21: R125–134.
18. TheryC, ZitvogelL, AmigorenaS (2002) Exosomes: composition, biogenesis and function. Nature reviews Immunology 2: 569–579.
19. Momen-HeraviF, BalajL, AlianS, TiggesJ, ToxavidisV, et al. (2012) Alternative methods for characterization of extracellular vesicles. Frontiers in physiology 3: 354.
20. YangM, ChenJ, SuF, YuB, SuF, et al. (2011) Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cells. Molecular cancer 10: 117.
21. PietschmannT, LohmannV, KaulA, KriegerN, RinckG, et al. (2002) Persistent and transient replication of full-length hepatitis C virus genomes in cell culture. Journal of virology 76: 4008–4021.
22. GastaminzaP, DrydenKA, BoydB, WoodMR, LawM, et al. (2010) Ultrastructural and biophysical characterization of hepatitis C virus particles produced in cell culture. Journal of virology 84: 10999–11009.
23. MasciopintoF, GiovaniC, CampagnoliS, Galli-StampinoL, ColombattoP, et al. (2004) Association of hepatitis C virus envelope proteins with exosomes. European journal of immunology 34: 2834–2842.
24. DreuxM, GaraigortaU, BoydB, DecembreE, ChungJ, et al. (2012) Short-range exosomal transfer of viral RNA from infected cells to plasmacytoid dendritic cells triggers innate immunity. Cell Host Microbe 12: 558–570.
25. WakitaT, PietschmannT, KatoT, DateT, MiyamotoM, et al. (2005) Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nature medicine 11: 791–796.
26. WilsonJA, ZhangC, HuysA, RichardsonCD (2011) Human Ago2 is required for efficient microRNA 122 regulation of hepatitis C virus RNA accumulation and translation. Journal of virology 85: 2342–2350.
27. HenkeJI, GoergenD, ZhengJ, SongY, SchuttlerCG, et al. (2008) microRNA-122 stimulates translation of hepatitis C virus RNA. The EMBO journal 27: 3300–3310.
28. JoplingCL, SchutzS, SarnowP (2008) Position-dependent function for a tandem microRNA miR-122-binding site located in the hepatitis C virus RNA genome. Cell host & microbe 4: 77–85.
29. JoplingCL, YiM, LancasterAM, LemonSM, SarnowP (2005) Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science 309: 1577–1581.
30. JangraRK, YiM, LemonSM (2010) Regulation of hepatitis C virus translation and infectious virus production by the microRNA miR-122. Journal of virology 84: 6615–6625.
31. BukongTN, HouW, KodysK, SzaboG (2013) Ethanol facilitates hepatitis C virus replication via up-regulation of GW182 and heat shock protein 90 in human hepatoma cells. Hepatology 57: 70–80.
32. WileyRD, GummuluruS (2006) Immature dendritic cell-derived exosomes can mediate HIV-1 trans infection. Proceedings of the National Academy of Sciences of the United States of America 103: 738–743.
33. RiceCM (2011) New insights into HCV replication: potential antiviral targets. Topics in antiviral medicine 19: 117–120.
34. BroeringTJ, GarrityKA, BoatrightNK, SloanSE, SandorF, et al. (2009) Identification and characterization of broadly neutralizing human monoclonal antibodies directed against the E2 envelope glycoprotein of hepatitis C virus. Journal of virology 83: 12473–12482.
35. AkazawaD, DateT, MorikawaK, MurayamaA, MiyamotoM, et al. (2007) CD81 expression is important for the permissiveness of Huh7 cell clones for heterogeneous hepatitis C virus infection. Journal of virology 81: 5036–5045.
36. BartoschB, DubuissonJ, CossetFL (2003) Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes. The Journal of experimental medicine 197: 633–642.
37. BukongTN, HouW, KodysK, SzaboG (2012) Ethanol facilitates HCV replication via upregulation of GW182 and HSP90 in human hepatoma cells. Hepatology 10.1002/hep.26010.
38. ShimakamiT, YamaneD, JangraRK, KempfBJ, SpanielC, et al. (2012) Stabilization of hepatitis C virus RNA by an Ago2-miR-122 complex. Proceedings of the National Academy of Sciences of the United States of America 109: 941–946.
39. ShimakamiT, YamaneD, JangraRK, KempfBJ, SpanielC, et al. (2012) Stabilization of hepatitis C virus RNA by an Ago2-miR-122 complex. Proceedings of the National Academy of Sciences of the United States of America 109: 941–946.
40. UjinoS, YamaguchiS, ShimotohnoK, TakakuH (2009) Heat-shock protein 90 is essential for stabilization of the hepatitis C virus nonstructural protein NS3. J Biol Chem 284: 6841–6846.
41. TscherneDM, JonesCT, EvansMJ, LindenbachBD, McKeatingJA, et al. (2006) Time- and temperature-dependent activation of hepatitis C virus for low-pH-triggered entry. Journal of virology 80: 1734–1741.
42. MeertensL, BertauxC, DragicT (2006) Hepatitis C virus entry requires a critical postinternalization step and delivery to early endosomes via clathrin-coated vesicles. Journal of virology 80: 11571–11578.
43. ParoliniI, FedericiC, RaggiC, LuginiL, PalleschiS, et al. (2009) Microenvironmental pH is a key factor for exosome traffic in tumor cells. The Journal of biological chemistry 284: 34211–34222.
44. SimonsM, RaposoG (2009) Exosomes–vesicular carriers for intercellular communication. Current opinion in cell biology 21: 575–581.
45. Momen-HeraviF, BalajL, AlianS, MantelPY, HalleckAE, et al. (2013) Current methods for the isolation of extracellular vesicles. Biological chemistry 10.1515/hsz-2013-0141.
46. SilvermanJM, ReinerNE (2011) Exosomes and other microvesicles in infection biology: organelles with unanticipated phenotypes. Cellular microbiology 13: 1–9.
47. BhatnagarS, ShinagawaK, CastellinoFJ, SchoreyJS (2007) Exosomes released from macrophages infected with intracellular pathogens stimulate a proinflammatory response in vitro and in vivo. Blood 110: 3234–3244.
48. RamakrishnaiahV, ThumannC, FofanaI, HabersetzerF, PanQ, et al. (2013) Exosome-mediated transmission of hepatitis C virus between human hepatoma Huh7.5 cells. Proceedings of the National Academy of Sciences of the United States of America 110: 13109–13113.
49. BlightKJ, McKeatingJA, RiceCM (2002) Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication. Journal of virology 76: 13001–13014.
50. HaoJ, JinW, LiX, WangS, ZhangX, et al. (2013) Inhibition of alpha interferon (IFN-alpha)-induced microRNA-122 negatively affects the anti-hepatitis B virus efficiency of IFN-alpha. J Virol 87: 137–147.
51. Sarasin-FilipowiczM, KrolJ, MarkiewiczI, HeimMH, FilipowiczW (2009) Decreased levels of microRNA miR-122 in individuals with hepatitis C responding poorly to interferon therapy. Nature medicine 15: 31–33.
52. JohnstonM, GeoffroyMC, SobalaA, HayR, HutvagnerG (2010) HSP90 protein stabilizes unloaded argonaute complexes and microscopic P-bodies in human cells. Molecular biology of the cell 21: 1462–1469.
53. OkamotoT, NishimuraY, IchimuraT, SuzukiK, MiyamuraT, et al. (2006) Hepatitis C virus RNA replication is regulated by FKBP8 and Hsp90. The EMBO journal 25: 5015–5025.
54. UjinoS, YamaguchiS, ShimotohnoK, TakakuH (2009) Heat-shock protein 90 is essential for stabilization of the hepatitis C virus nonstructural protein NS3. J Biol Chem 284: 6841–6846.
55. TheryC, ZitvogelL, AmigorenaS (2002) Exosomes: composition, biogenesis and function. Nature reviews Immunology 2: 569–579.
56. DenzerK, KleijmeerMJ, HeijnenHF, StoorvogelW, GeuzeHJ (2000) Exosome: from internal vesicle of the multivesicular body to intercellular signaling device. Journal of cell science 113 Pt 19: 3365–3374.
57. SobotaJA, BackN, EipperBA, MainsRE (2009) Inhibitors of the V0 subunit of the vacuolar H+-ATPase prevent segregation of lysosomal- and secretory-pathway proteins. Journal of cell science 122: 3542–3553.
58. Alvarez-ErvitiL, SeowY, SchapiraAH, GardinerC, SargentIL, et al. (2011) Lysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmission. Neurobiology of disease 42: 360–367.
59. VingtdeuxV, HamdaneM, LoyensA, GeleP, DrobeckH, et al. (2007) Alkalizing drugs induce accumulation of amyloid precursor protein by-products in luminal vesicles of multivesicular bodies. The Journal of biological chemistry 282: 18197–18205.
60. BlanchardE, BelouzardS, GoueslainL, WakitaT, DubuissonJ, et al. (2006) Hepatitis C virus entry depends on clathrin-mediated endocytosis. Journal of virology 80: 6964–6972.
61. LimJH, ParkJW, KimMS, ParkSK, JohnsonRS, et al. (2006) Bafilomycin induces the p21-mediated growth inhibition of cancer cells under hypoxic conditions by expressing hypoxia-inducible factor-1alpha. Molecular pharmacology 70: 1856–1865.
62. LindenbachBD, EvansMJ, SyderAJ, WolkB, TellinghuisenTL, et al. (2005) Complete replication of hepatitis C virus in cell culture. Science 309: 623–626.
63. BalaS, PetrasekJ, MundkurS, CatalanoD, LevinI, et al. (2012) Circulating microRNAs in exosomes indicate hepatocyte injury and inflammation in alcoholic, drug-induced, and inflammatory liver diseases. Hepatology 56: 1946–1957.
64. ItoT, MukaigawaJ, ZuoJ, HirabayashiY, MitamuraK, et al. (1996) Cultivation of hepatitis C virus in primary hepatocyte culture from patients with chronic hepatitis C results in release of high titre infectious virus. The Journal of general virology 77 (Pt 5) 1043–1054.
65. BukongTN, KodysK, SzaboG (2013) Human ezrin-moesin-radixin proteins modulate hepatitis C virus infection. Hepatology 58: 1569–1579.